share_log

Cullinan Oncology Q4 EPS $(0.54) Beats $(0.96) Estimate; Cash And Investments Of $468.3M As Of December 31, 2023 Continues To Provide Runway Into The Second Half Of 2026

Moomoo 24/7 ·  Mar 14 07:16

Cullinan Oncology (NASDAQ:CGEM) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.96) by 43.75 percent. This is a 40.66 percent increase over losses of $(0.91) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment